Citrato liasi ATP
ATP Citrate Lyase inhibitors are compounds that target the enzyme ATP citrate lyase, which plays a key role in the biosynthesis of fatty acids and cholesterol by converting citrate to acetyl-CoA. In the context of neuroscience, these inhibitors are of interest due to their potential effects on lipid metabolism in the brain, which is crucial for maintaining neuronal function and integrity. Inhibiting ATP citrate lyase can have implications for neurodegenerative diseases, where lipid metabolism is often dysregulated. At CymitQuimica, we offer ATP citrate lyase inhibitors to support your research in brain metabolism, neurodegeneration, and therapeutic development.
Trovati 18 prodotti per "Citrato liasi ATP".
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Citric acid trilithium salt tetrahydrate
CAS:Citric acid trilithium salt tetrahydrate (Lithium citrate tribasic tetrahydrate) , the active component of Lithium, is a medicine used in the therapy ofFormula:C6H13Li3O11Purezza:99.88%Colore e forma:White SolidPeso molecolare:281.98Hydroxycitric acid tripotassium hydrate
CAS:Hydroxycitric acid tripotassium hydrate (Potassium citrate monohydrate) effectively inhibits HIF, has antioxidation, anti-inflammation, and anti-tumor effects.Formula:C6H7K3O8Purezza:99.85%Colore e forma:White Solid CrystallinePeso molecolare:324.41(-)-Hydroxycitric acid lactone
CAS:(-)-Hydroxycitric acid lactone (Garcinia lactone) is an anti-obesity agent.(-)-Hydroxycitric acid lactone was a potent inhibitor of ATP citrate lyase, whichFormula:C6H6O7Purezza:99.85% - 99.91%Colore e forma:White SolidPeso molecolare:190.11(-)-Hydroxycitric acid
CAS:(-)-Hydroxycitric acid from Garcinia cambogia rinds inhibits ATP citrate lyase, reducing fat synthesis and aiding weight loss.Formula:C6H8O8Purezza:99.18% - 99.90%Colore e forma:SolidPeso molecolare:208.12Forrestiacids K
CAS:Forrestiacid K, a terpenoid derived from Pseudotsuga forrestii, functions as an inhibitor of ATP-citrate lyase (ACL) [1].Formula:C50H74O6Purezza:98%Colore e forma:SolidPeso molecolare:771.12Forrestiacids J
CAS:Forrestiacid J is an inhibitor of ATP-citrate lyase (ACL), exhibiting an IC50 value of 2.6 μM [1].Formula:C50H74O6Purezza:98%Colore e forma:SolidPeso molecolare:771.12ATP citrate lyase/ACLY Protein, Human, Recombinant (His)
ATP citrate lyase, also known as Acly or Acl, is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues.Purezza:96%Colore e forma:Transparent SolutionPeso molecolare:123 kDa (predicted); 110 kDa (reducing conditions)Anti-ATP citrate lyase/ACLY Antibody (9F685)
Anti-ATP citrate lyase/ACLY Antibody (9F685) is an antibody targeting ATP citrate lyase/ACLY. Anti-ATP citrate lyase/ACLY Antibody (9F685) can be used in ELISA, WB, IF, FCM.Colore e forma:Odour LiquidSB 204990
CAS:SB 204990 is a lactone prodrug of SB-201076, a potent and specific ATP citrate lyase inhibitor.Cost-effective and quality-assured.Formula:C18H22Cl2O5Purezza:96.32% - 99.6%Colore e forma:SolidPeso molecolare:389.27BMS-303141
CAS:BMS-303141 is a potent ATP-citrate lyase (ACL) inhibitor (IC50: 0.13 uM, human recombinant ACL).Formula:C19H15Cl2NO4SPurezza:98% - 99.47%Colore e forma:White SolidPeso molecolare:424.3Ref: TM-T2337
1mg34,00€2mg44,00€5mg63,00€1mL*10mM (DMSO)65,00€10mg82,00€25mg133,00€50mg254,00€100mg371,00€2-Furoic acid
CAS:2-Furoic acid: oral cathepsin K inhibitor, potential for treating osteoporosis and antibacterial.Formula:C5H4O3Purezza:99.53% - 99.65%Colore e forma:White SolidPeso molecolare:112.08NDI-091143
CAS:NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay),indirectly disrupting citrate bindingFormula:C20H14ClF2NO5SPurezza:97.03% - ≥95%Colore e forma:SolidPeso molecolare:453.84Bempedoic acid
CAS:Bempedoic acid (ETC1002) is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C.Formula:C19H36O5Purezza:99.85% - 99.94%Colore e forma:White SolidPeso molecolare:344.49Ref: TM-T3625
2mg34,00€5mg50,00€1mL*10mM (DMSO)52,00€10mg70,00€25mg118,00€50mg207,00€100mg333,00€500mg797,00€EVT0185
CAS:EVT0185 is an orally active ATP citrate lyase (ACLY) inhibitor. In the liver, it is converted by SLC27A2 into a CoA thioester, which interacts with the CoA binding site of ACLY. EVT0185-CoA inhibits ACLY activity with an IC50 of 2.5 μM. It mimics the immune and antitumor effects seen with ACLY gene deletion. Additionally, EVT0185 elevates levels of tumor-infiltrating B cells and the chemokine CXCL13. It is applicable in cancer research, including hepatocellular carcinoma (HCC).Formula:C22H34O4Colore e forma:SolidPeso molecolare:362.50MEDICA16
CAS:MEDICA16: GPR40 agonist, GPR120 partial agonist, ATP-citrate lyase inhibitor, lowers TG, boosts insulin sensitivity in muscle.Formula:C20H38O4Purezza:99.62% - 99.87%Colore e forma:SolidPeso molecolare:342.51Ref: TM-T22967
5mg60,00€1mL*10mM (DMSO)80,00€10mg92,00€25mg168,00€50mg289,00€100mg419,00€500mg874,00€ACLY-IN-1
CAS:ACLY-IN-1 (compound 55) is a potent ACLY inhibitor with an IC50 of 8.3 nM, and it can be utilized in hyperlipidemia research.Formula:C20H12BrClF2N2O4SColore e forma:SolidPeso molecolare:529.74ACLY Inhibitor 7
CAS:ACLY Inhibitor 7 is a potent, selective hACLY inhibitor (IC50<1 nM) for metabolic disease and oncology research.Formula:C21H14ClF2NO6SPurezza:99.74%Colore e forma:SolidPeso molecolare:481.85BGT-002
CAS:BGT-002 (326E) is an orally active dual ACLY inhibitor and PPARα agonist. It reduces lipogenesis by inhibiting synthesis and promoting excretion. BGT-002 has demonstrated efficacy in vivo for improving metabolic dysfunction-associated steatohepatitis (MASH) and alleviating hyperlipidemia. It is applicable for research on hypercholesterolemia and MASH.Formula:C19H34O4Peso molecolare:326.48
